Roivant Sciences Ltd. (ROIV)
32.41
+4.20
(+14.89%)
USD |
NASDAQ |
May 20, 16:00
32.35
-0.06
(-0.19%)
After-Hours: 17:14
Roivant Sciences Total Assets (Quarterly) : 5.225B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arbutus Biopharma Corp. | 277.16M |
| Moderna, Inc. | 11.49B |
| Centessa Pharmaceuticals Plc | 641.76M |
| Silence Therapeutics Plc | 115.12M |
| Adaptimmune Therapeutics Plc | 130.63M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 251.14M |
| Shareholders Equity (Quarterly) | 4.269B |
| Debt to Equity Ratio | 0.0255 |
| Current Ratio | 30.66 |
| Net Debt Paydown Yield | -0.07% |